431 related articles for article (PubMed ID: 16495522)
1. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
2. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
Logsdon LK; Mecsas J
Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
[TBL] [Abstract][Full Text] [Related]
3. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
4. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
[TBL] [Abstract][Full Text] [Related]
5. Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice.
Holmström A; Rosqvist R; Wolf-Watz H; Forsberg A
Infect Immun; 1995 Jun; 63(6):2269-76. PubMed ID: 7768608
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model.
Trülzsch K; Sporleder T; Igwe EI; Rüssmann H; Heesemann J
Infect Immun; 2004 Sep; 72(9):5227-34. PubMed ID: 15322017
[TBL] [Abstract][Full Text] [Related]
7. In vivo expression of virulence genes of Yersinia pseudotuberculosis.
Forsberg A; Rosqvist R
Infect Agents Dis; 1993 Aug; 2(4):275-8. PubMed ID: 8173809
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.
Dessein R; Gironella M; Vignal C; Peyrin-Biroulet L; Sokol H; Secher T; Lacas-Gervais S; Gratadoux JJ; Lafont F; Dagorn JC; Ryffel B; Akira S; Langella P; Nùñez G; Sirard JC; Iovanna J; Simonet M; Chamaillard M
Gut; 2009 Jun; 58(6):771-6. PubMed ID: 19174417
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
10. The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.
Schiano CA; Bellows LE; Lathem WW
Infect Immun; 2010 May; 78(5):2034-44. PubMed ID: 20231416
[TBL] [Abstract][Full Text] [Related]
11. Galectin-1-Driven Tolerogenic Programs Aggravate
Davicino RC; Méndez-Huergo SP; Eliçabe RJ; Stupirski JC; Autenrieth I; Di Genaro MS; Rabinovich GA
J Immunol; 2017 Aug; 199(4):1382-1392. PubMed ID: 28716827
[No Abstract] [Full Text] [Related]
12. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
13. In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence.
Pisano F; Kochut A; Uliczka F; Geyer R; Stolz T; Thiermann T; Rohde M; Dersch P
Infect Immun; 2012 Mar; 80(3):1050-64. PubMed ID: 22158741
[TBL] [Abstract][Full Text] [Related]
14. Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.
Thorslund SE; Ermert D; Fahlgren A; Erttmann SF; Nilsson K; Hosseinzadeh A; Urban CF; Fällman M
Infect Immun; 2013 Jan; 81(1):11-22. PubMed ID: 23090955
[TBL] [Abstract][Full Text] [Related]
15. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
16. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection.
Durand EA; Maldonado-Arocho FJ; Castillo C; Walsh RL; Mecsas J
Cell Microbiol; 2010 Aug; 12(8):1064-82. PubMed ID: 20148898
[TBL] [Abstract][Full Text] [Related]
17. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
Sundberg L; Forsberg A
Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
[TBL] [Abstract][Full Text] [Related]
18. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
[TBL] [Abstract][Full Text] [Related]
19. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain.
Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS
Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935
[TBL] [Abstract][Full Text] [Related]
20. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
